|
CDH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29949995208989E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.98129965159433E-10 |
| Normal-vs-Stage2 |
3.31389999885801E-08 |
| Normal-vs-Stage3 |
1.578410E-01 |
| Normal-vs-Stage4 |
8.1180000000014E-05 |
| Stage1-vs-Stage2 |
5.863200E-01 |
| Stage1-vs-Stage3 |
1.048850E-01 |
| Stage1-vs-Stage4 |
8.201600E-01 |
| Stage2-vs-Stage3 |
7.447700E-02 |
| Stage2-vs-Stage4 |
9.507000E-01 |
| Stage3-vs-Stage4 |
1.495190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.38190023260643E-10 |
| Normal-vs-AfricanAmerican |
5.79019999946695E-07 |
| Normal-vs-Asian |
2.206200E-02 |
| Caucasian-vs-AfricanAmerican |
3.523400E-01 |
| Caucasian-vs-Asian |
7.653800E-02 |
| AfricanAmerican-vs-Asian |
2.646400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08740016990794E-10 |
| Normal-vs-Female |
1.789380E-04 |
| Male-vs-Female |
8.818500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.19529999999635E-05 |
| Normal-vs-Extreme_Weight |
1.65230051862864E-10 |
| Normal-vs-Obese |
3.383300E-04 |
| Normal-vs-Extreme_Obese |
3.93650000000134E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.969440E-01 |
| Normal_Weight-vs-Obese |
6.297800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.421800E-01 |
| Extreme_Weight-vs-Obese |
6.883700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.953800E-01 |
| Obese-vs-Extreme_Obese |
2.937000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.872300E-02 |
| Normal-vs-Age(41-60Yrs) |
9.72960000344969E-08 |
| Normal-vs-Age(61-80Yrs) |
9.69240243620106E-11 |
| Normal-vs-Age(81-100Yrs) |
8.64560000257697E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.857200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.746500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.730100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.516050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.768000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.390800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
7.88980000000494E-05 |
| Normal-VS-KIRP CIMP |
2.726800E-01 |
| Normal-VS-Unclassified PRCC |
1.182590E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.823700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.60380000002736E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.645800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.131200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.357800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.026600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.199800E-03 |
| Normal-vs-N1 |
1.248750E-04 |
| Normal-vs-N2 |
3.016300E-02 |
| N0-vs-N1 |
9.927600E-01 |
| N0-vs-N2 |
9.995600E-01 |
| N1-vs-N2 |
9.960000E-01 |
|
|
